Funding announced in the 2019–20 Budget to implement the outcomes of the third review

The Australian Government will meet 50% of the cost of implementing the recommendations of the third review of the National Gene Technology Scheme. Remaining costs will be met by the states and territories under an all Australian governments agreement.